A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer

被引:24
作者
Hu, Yuhang [1 ]
Wang, Fan [1 ]
Xu, Fengyu [1 ]
Fang, Kaifeng [1 ]
Fang, Zhi [1 ]
Shuai, Xiaoming [2 ]
Cai, Kailin [2 ]
Chen, Jinhuang [1 ]
Hu, Ping [1 ]
Chen, Ding [1 ]
Xu, Peng [1 ]
Hu, Chaojie [1 ]
Zeng, Zhu [1 ]
Zhong, Jianxin [1 ]
Li, Wei [1 ]
Tang, Jiang [1 ]
Huang, Mengqi [1 ]
Zhao, Yong [1 ]
Wang, Chunyou [3 ]
Zhao, Gang [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Emergency Surg, Wuhan 430022, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastroenterol Surg, Wuhan 430022, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pancreat Surg, Wuhan 430022, Peoples R China
来源
THERANOSTICS | 2020年 / 10卷 / 22期
基金
美国国家科学基金会;
关键词
Acidity; LncRNA; metastasis; MTSS1-AS; Myc; C-MYC; IN-VIVO; PH; TRANSCRIPTION; PROGRESSION; EXPRESSION; HYPOXIA; MICROENVIRONMENT; OVEREXPRESSION; METABOLISM;
D O I
10.7150/thno.49147
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Rationale: Previous studies have reported on the role of extracellular acidity in the metastasis of numerous cancers. However, the involvement of long noncoding RNA (lncRNA) in the extracellular acidity-induced cancer metastasis of pancreatic cancer (PC) remains unclear. Methods: Different expression levels of lncRNAs in PC cells under normal and acidic conditions were compared by RNA sequencing (RNA-seq). The effects of antisense lncRNA of metastasis suppressor 1 (MTSS1-AS) on acidic PC cells were assessed by gain- and loss-of-function experiments. Fluorescence in situ hybridization, RNA immunoprecipitation, RNA pull-down, Western blot, luciferase reporter, and Chromatin immunoprecipitation assays were employed to determine the regulatory mechanisms of MTSS1-AS in the acidity-induced metastasis of PC cells. The expression of MTSS1-AS and associated pathways were compared in PC samples and peritumoral normal tissues. Results: RNA-seq demonstrated that MTSS1-AS was significantly downregulated in pancreatic cells cultured with the acidic medium. The overexpression of MTSS1-AS remarkably inhibited the acidity-promoted metastasis of PC cells by upregulating the expression of its sense gene metastasis suppressor 1 (MTSS1). Mechanistically, MTSS1-AS scaffolded the interaction between E3 ubiquitin-protein ligase STIP1 homology and U-box containing protein 1 (STUB1) and transcription regulator myeloid zinc finger 1 (MZF1), leading to ubiquitination-mediated degradation of MZF1. Further, MZF1 inhibited the expression of MTSS1 by binding to the MTSS1 promoter. Thus, the acidity-reduced MTSS1-AS facilitated the stability of MZF1 and its inhibitory effect on MTSS1 transcription, thereby promoting the metastasis of PC cells under acidic conditions. Moreover, MTSS1-AS was transcriptionally repressed by the binding of MYC proto-oncogene (Myc) with initiator (Inr) elements of the MTSS1-AS promoter. Meanwhile, MTSS1-AS mutually repressed the expression of Myc by impairing the MZF1-mediated transcription activation of Myc, thereby forming a negative feedback loop between MTSS1-AS and Myc in acidic PC cells. In accordance with the experimental results, MTSS1-AS and MTSS1 were downregulated in PC and correlated with poor overall survival. Conclusions: The results implicated that a reciprocal feedback loop between Myc and MTSS1-AS contributed to the extracellular acidity-promoted metastasis of PC, and indicated that MTSS1-AS was a valuable biomarker and therapeutic target for PC.
引用
收藏
页码:10120 / 10140
页数:21
相关论文
共 57 条
[1]  
[Anonymous], 2019, CELL CYCLE, DOI DOI 10.1080/15384101.2019.1578145
[2]  
[Anonymous], 2011, NAT REV CANCER, DOI DOI 10.1038/NRC3110
[3]  
[Anonymous], 2010, BMC CANCER, DOI DOI 10.1186/1471-2407-10-428
[4]  
[Anonymous], 2018, CANCER RES, DOI DOI 10.1158/0008-5472.CAN-16-2140
[5]  
[Anonymous], 2017, CELL DEATH DIS, DOI DOI 10.1038/CDDIS.2017.189
[6]  
[Anonymous], 2020, EXP CELL RES, DOI DOI 10.1016/J.YEXCR.2020.111984
[7]  
[Anonymous], 2013, DEVELOPMENT, DOI DOI 10.1242/DEV.099390
[8]  
[Anonymous], 2003, NEOPLASIA
[9]  
[Anonymous], 2019, THERANOSTICS, DOI DOI 10.7150/THNO.30988
[10]  
[Anonymous], 2020, CLIN CANCER RES, DOI DOI 10.1158/1078-0432.CCR-19-0674